Skip to main content
Clinical Trials/NL-OMON52735
NL-OMON52735RecruitingPhase 4

A randomized clinical trial to evaluate the efficacy of polyethylene glycol vs psyllium fiber to prevent rebleeding in patients hospitalized with bleeding diverticular disease. - Prevention of rebleeding in diverticular disease.

Elisabeth-Tweesteden ziekenhuis0 sites260 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Recruiting
Sponsor
Enrollment
260

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Patients between the ages of 18 or older.
  • Patients who are hospitalized for bleeding diverticular disease in het ETZ.
  • Patients with diverticular disease based on colonoscopy, sigmoïdscopy or
  • CT-scan <5 years

Exclusion Criteria

  • Other bleeding diseases of the colon requiring medicinal treatment such as IBD
  • or infection
  • Surgical treatment following initial episode of bleeding diverticular disease.
  • Patients using polyethylene glycol or psyllium fiber regularly, more than twice
  • Patients who are pregnant, lactating or planning pregnancy while enrolled in
  • Patients who are unsuitable for inclusion in the study in the opinion of the
  • investigator for any reason that may compromise the subject*s safety or
  • confound data interpretation

Investigators

Sponsor
Elisabeth-Tweesteden ziekenhuis

Similar Trials